Lastly, BRAF and NRAS point mutations were identified in primary extranodal DLBCL of the thyroid, suggesting a role of the RAS-MAPK pathway alteration in the pathogenesis of DLBCL developing in the thyroid gland [69,70]. Here, NRAS is linked to diffuse large B-cell lymphoma.